Skip to main content
. 2020 Jun 16;12:4585–4593. doi: 10.2147/CMAR.S247554

Figure 1.

Figure 1

Flow diagram of patient selection and analysis according to the development of irAEs.

Abbreviations: GC, gastric cancer; ICIs, immune checkpoint inhibitors; irAEs, immune-related adverse events; MM, malignant melanoma; NSCLC, non-small-cell lung cancer; RCC, renal cell carcinoma.